1. Drug Industry Efforts:
Individual Company and Multi-Manufacturer
Karen O. Gibbs, Esq.
Partner, Sidley Austin LLP – Chicago, IL

2. Individual Company Efforts
Patient Assistance Programs (“PAP”s)
Individual Company Savings Cards
Participation in Multi-Manufacturer Savings Cards
Support of Industry Work (e.g., PPA)
Helping Patients to Afford Prescriptions

3. Patient Assistance Programs (“ “s)
PAP
Free Drugs
Patient Qualifications
typically, % FPL
physician participation
shipment of product
Some Companies Offer Product-Specific Programs

4. Downsides for Patients
PAPs
Upsides for Patients
F R E E !
Downsides for Patients
Substantial Paperwork
Involvement of Physicians/Stigma
Typical Patient Needs to Enroll in Multiple PAPs

5. Upsides for Manufacturers
PAPs
Upsides for Manufacturers
Cost-effective
OIG Support for Free Product Programs
Downsides for Manufacturers
Heavy Administration

6. Individual Company Savings Cards
Savings at the Pharmacy Counter
Most Patients Would Need Multiple Cards
Largely Replaced with PAPs and Multi-Company Savings Programs

7. Participation in Multi-Manufacturer Savings Cards
Savings at the Pharmacy Counter
Easy for Patients
Savings on Many Companies’ Products

8. Support of Industry Work
Partnership for Prescription Assistance

9. World Offices